Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Publication year range
1.
Mol Nutr Food Res ; 60(2): 420-9, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26548572

ABSTRACT

SCOPE: Emerging evidence indicates that the use of bioactive food components is a promising strategy to prevent the development of liver cancer. The goal of this study was to examine the chemopreventive effect of butyrate-containing structured lipids (STLs) produced by an enzymatic interesterification of tributyrin and flaxseed oil on rat hepatocarcinogenesis. METHODS AND RESULTS: Male Wistar rats were subjected to a classic "resistant hepatocyte" model of liver carcinogenesis and treated with STLs, tributyrin or flaxseed oil during the initial phases of hepatocarcinogenesis. Treatment with STLs and tributyrin strongly inhibited the development of preneoplastic liver lesions. The chemopreventive activity of tributyrin was associated with the induction of apoptosis and reduction of the expression of major activated hepatocarcinogenesis-related oncogenes. Treatment with STLs caused substantially greater inhibitory effects than tributyrin on oncogene expression. CONCLUSION: These results demonstrate that the tumor-suppressing activity of butyrate-containing STLs is associated with its ability to prevent and inhibit activation of major hepatocarcinogenesis-related oncogenes. Enrichment of histone H3K9me3 and H3K27me3 at the promoter of Myc and Ccnd1 genes may be related to the inhibitory effect on oncogene expression in the livers of STL-treated rats.


Subject(s)
Anticarcinogenic Agents/pharmacology , Butyric Acid/pharmacology , Liver Neoplasms, Experimental/prevention & control , Animals , Anticarcinogenic Agents/chemistry , Butyric Acid/chemistry , Gene Expression Regulation/drug effects , Histones/genetics , Histones/metabolism , Linseed Oil/chemistry , Lipids/chemistry , Lipids/pharmacology , Liver Neoplasms, Experimental/pathology , Male , Oncogenes , Precancerous Conditions/genetics , Precancerous Conditions/pathology , Precancerous Conditions/prevention & control , Rats, Wistar , Triglycerides/chemistry , Triglycerides/pharmacology
2.
Int J Cancer ; 135(1): 7-18, 2014 Jul 01.
Article in English | MEDLINE | ID: mdl-24302446

ABSTRACT

The steady increase in the incidence and mortality of hepatocellular carcinoma (HCC) signifies a crucial need to understand better its pathogenesis to improve clinical management and prevention of the disease. The aim of this study was to investigate molecular mechanisms for the chemopreventive effects of folic acid and tributyrin alone or in combination on rat hepatocarcinogenesis. Male Wistar rats were subjected to a classic "resistant hepatocyte" model of liver carcinogenesis and treated with folic acid and tributyrin alone or in combination for 5 weeks during promotion stage. Treatment with folic acid and tributyrin alone or in combination strongly inhibited the development of glutathione-S-transferase placental form (GSTP)-positive foci. Microarray analysis showed significant changes in gene expression. A total of 498, 655 and 940 of differentially expressed genes, involved in cell cycle, p53-signaling, angiogenesis and Wnt pathways, was identified in the livers of rats treated with folic acid, tributyrin or folic acid and tributyrin. A detailed analysis of these differentially expressed genes revealed that treatments inhibited angiogenesis in the preneoplastic livers. This was evidenced by the fact that 30 out of 77 differentially expressed genes common to all three treatments are involved in the regulation of the angiogenesis pathway. The inhibition of angiogenesis was confirmed by reduced levels of CD34 protein. In conclusion, the tumor-suppressing activity of folic acid and tributyrin is associated with inhibition of angiogenesis at early stages of rat liver carcinogenesis. Importantly, the combination of folic acid and tributyrin has stronger chemopreventive effect than each of the compounds alone.


Subject(s)
Carcinoma, Hepatocellular/drug therapy , Folic Acid/administration & dosage , Liver Neoplasms/drug therapy , Triglycerides/administration & dosage , Animals , Antigens, CD34/metabolism , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carcinogenesis/chemically induced , Carcinogenesis/drug effects , Carcinogenesis/pathology , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Diethylnitrosamine/toxicity , Gene Expression Regulation, Neoplastic/drug effects , Glutathione S-Transferase pi/metabolism , Humans , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Male , Neoplasm Proteins/biosynthesis , Neovascularization, Pathologic/drug therapy , Rats , Transcriptome/genetics
3.
J Nutrigenet Nutrigenomics ; 6(3): 125-36, 2013.
Article in English | MEDLINE | ID: mdl-23942415

ABSTRACT

BACKGROUND/AIMS: Chronic alcoholism is characterized by hepatotoxicity associated with antioxidant and redox status imbalance. Continuous ethanol intake induces free radical synthesis, resulting in the depletion of antioxidants, especially α-tocopherol, which has an important role in lipid peroxidation. This study aimed to evaluate if α-tocopherol supplementation can restore liver phenotype in rats chronically exposed to ethanol. METHODS: α-Tocopherol levels were determined and histologic analysis of liver was performed. Hepatic gene expression was analyzed through oligonucleotide microarray and real-time PCR. RESULTS: Alcohol exposure for 6 weeks did not decrease hepatic α-tocopherol levels; however, both groups exposed to ethanol (supplemented or not with α-tocopherol) displayed fatty liver. The antioxidant supplementation prevented Mallory bodies and inflammatory infiltration, but not apoptosis, in liver of the rats exposed to ethanol. Gene expression analysis showed evidence of adaptive response to chronic alcohol consumption, where antioxidant components were not regulated. Nevertheless, differentially expressed genes reflected the change in cellular homeostasis. CONCLUSION: The hepatic α-tocopherol content was coherent with the antioxidant gene expression in this study. Cells are likely to have adapted and restored their antioxidant status after long-term ethanol exposure, which might be the reason for such conflicting reports concerning α-tocopherol status in chronic alcoholism.


Subject(s)
Ethanol/toxicity , Liver/drug effects , alpha-Tocopherol/administration & dosage , Animals , Base Sequence , Chromatography, High Pressure Liquid , DNA Primers , Dietary Supplements , Liver/pathology , Male , Oligonucleotide Array Sequence Analysis , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Spectrophotometry, Ultraviolet , alpha-Tocopherol/pharmacology
4.
Carcinogenesis ; 34(8): 1900-6, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23568954

ABSTRACT

The reversibility of non-genotoxic phenotypic alterations has been explored in order to develop novel preventive and therapeutic approaches for cancer control. Previously, it has been demonstrated that histone deacetylase (HDAC) inhibitor tributyrin, a butyric acid prodrug, to have chemopreventive effects on rat hepatocarcinogenesis. The goal of this study was to determine molecular mechanisms associated with the chemopreventive activity of tributyrin. Male Wistar rats were allocated randomly to untreated control group and two experimental groups. Rats in the experimental group 1 were treated with maltodextrin (3g/kg body wt), and rats in experimental group 2 were treated with tributyrin (2g/kg body wt) daily for 8 weeks. Two weeks after treatment initiation, rats from experimental groups were subjected to a 'resistant hepatocyte' model of hepatocarcinogenesis. Treatment with tributyrin resulted in lower HDAC activity and Hdac3 and Hdac4 gene expression, and an increase of histone H3 lysine 9 and 18 and histone H4 lysine 16 acetylation as compared with the experimental group 1. In addition to the increase in histone acetylation, tributyrin caused an increase in the acetylation of the nuclear p53 protein. These changes were accompanied by a normalization of the p53-signaling network, particularly by the upregulation of pro-apoptotic genes, and a consequent increase of apoptosis and autophagy in the livers of tributyrin-treated rats. These results indicate that the chemopreventive activity of tributyrin may be related to an increase of histone and p53 acetylation, which could lead to the induction of the p53 apoptotic pathway.


Subject(s)
Apoptosis/drug effects , Butyric Acid/pharmacology , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/prevention & control , Prodrugs/pharmacology , Triglycerides/pharmacology , Tumor Suppressor Protein p53/genetics , Acetylation , Animals , Apoptosis/genetics , Carcinogenesis/genetics , Carcinogenesis/metabolism , Carcinogenesis/pathology , Hepatocytes/drug effects , Hepatocytes/metabolism , Hepatocytes/pathology , Histone Deacetylase Inhibitors/pharmacology , Histone Deacetylases/genetics , Histone Deacetylases/metabolism , Histones/genetics , Histones/metabolism , Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/pathology , Lysine/genetics , Lysine/metabolism , Male , Precancerous Conditions/drug therapy , Precancerous Conditions/genetics , Precancerous Conditions/metabolism , Precancerous Conditions/pathology , Random Allocation , Rats , Rats, Wistar , Signal Transduction/drug effects , Signal Transduction/genetics , Tumor Suppressor Protein p53/metabolism , Up-Regulation/drug effects
5.
J Nutr Biochem ; 23(8): 860-6, 2012 Aug.
Article in English | MEDLINE | ID: mdl-21940155

ABSTRACT

The chemopreventive effects of tributyrin (TB) and vitamin A (VA), alone or in combination, were investigated during the promotion phase of rat hepatocarcinogenesis. Compared to diethylnitrosamine control rats, TB and TB+VA-treated rats, but not VA-treated rats, presented a lower incidence and mean number of hepatocyte nodules and a smaller size of persistent preneoplastic lesions (pPNLs). In addition, TB and TB+VA-treated rats exhibited a higher apoptotic body index in pPNL and remodeling PNL, whereas VA-treated rats presented only a higher apoptotic body index in remodeling PNL. None of the treatments inhibited cell proliferation in PNL. TB and TB+VA-treated rats, but not VA-treated rats, exhibited higher levels of H3K9 acetylation and p21 protein expression. TB and VA-treated rats exhibited increased hepatic concentrations of butyric acid and retinoids, respectively. Compared to normal rats, diethylnitrosamine control animals exhibited lower retinyl palmitate hepatic concentrations. All groups had similar expression levels and exhibited similar unmethylated CRBP-I promoter region in microdissected pPNL, indicating that epigenetic silencing of this gene was not involved in alteration of retinol metabolism in early hepatocarcinogenesis. Data support the effectiveness of TB as a dietary histone deacetylase inhibitor during the promotion phase of hepatocarcinogenesis, which should be considered for chemoprevention combination strategies.


Subject(s)
Anticarcinogenic Agents/pharmacology , Histone Deacetylase Inhibitors/pharmacology , Histone Deacetylases/metabolism , Liver/pathology , Precancerous Conditions/prevention & control , Triglycerides/pharmacology , Vitamin A/pharmacology , Animals , Apoptosis , Cell Proliferation , Chemoprevention , Hepatocytes/metabolism , Hepatocytes/pathology , Histones/metabolism , Liver/metabolism , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/pathology , Liver Neoplasms, Experimental/prevention & control , Male , Precancerous Conditions/metabolism , Precancerous Conditions/pathology , Rats , Rats, Wistar , rho GTP-Binding Proteins/metabolism
6.
Food Chem Toxicol ; 45(4): 563-7, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17113696

ABSTRACT

5-Azacytidine is being used for reactivation of tumor suppressor genes. However, its administration during DNA repair pontentiates hepatocarcinogenesis. We observed chemopreventive activities by vitamin A and beta-carotene during early hepatocarcinogenesis. Thus, in the present study we evaluated vitamin A and beta-carotene chemopreventive potential during early hepatocarcinogenesis potentiated by 5-azacytidine. Wistar rats received vitamin A (VAA group), beta-carotene (betaCA group) or corn oil (CO and COA groups). After three weeks of treatment, all animals were initiated with 1,2-dimethylhydrazine. Twelve hours later VAA, betaCA and COA groups received a single dose of 5-Azc. Hepatocytes were selected/promoted by 2-acetylaminofluorene and 70% partial hepatectomy. All animals were sacrificed six weeks after initiation. Compared to CO group (without 5-azacytidine), COA group presented higher (p<0.05) nodule multiplicity, larger (p<0.05) gamma-GT positive lesions that occupied a larger (p<0.05) area of liver section. Compared to COA group, VAA group presented decreased (p<0.05) nodule multiplicity while betaCA group tended to present smaller gamma-GT positive lesions and to decrease occupied liver section. These results reinforce vitamin A and beta-carotene chemopreventive potential. Considering that 5-azacytidine potentiates hepatocarcinogenesis, more studies are needed to elucidate the efficacy and safety of this drug for cancer control.


Subject(s)
1,2-Dimethylhydrazine/toxicity , Anticarcinogenic Agents/therapeutic use , Azacitidine/toxicity , Liver Neoplasms, Experimental/prevention & control , Vitamin A/therapeutic use , beta Carotene/therapeutic use , Animals , DNA Repair , Liver Neoplasms, Experimental/chemically induced , Male , Rats , Rats, Wistar , gamma-Glutamyltransferase/analysis
7.
Nutr Cancer ; 44(1): 80-8, 2002.
Article in English | MEDLINE | ID: mdl-12672634

ABSTRACT

The inhibitory effects of Beta-carotene and vitamin A administered to rats in the progression phase of the resistant hepatocyte model of hepatocarcinogenesis were investigated. Beta-Carotene- and vitamin A-treated animals tended to present with a lower incidence of hepatic cancers than controls at sacrifice. Vitamin A, but not Beta-carotene, administration also tended to reduce the total number of persistent hepatocyte nodules. Histological examination of sections stained with hematoxylin and eosin confirmed these results. This suggests that both compounds exhibit inhibitory effects during conversion of persistent nodules to cancers, whereas only the retinoid is also capable of inhibiting the evolution of persistent nodules or causing them to regress. Moreover, Beta-carotene- and vitamin A-treated animals showed lower hepatic bromodeoxyuridine labeling indexes in neoplastic lesions as well as in adjacent normal tissues than controls, suggesting an inhibitory action of these substances on cell proliferation. However, neither Beta-carotene nor vitamin A administration resulted in substantial alterations in the CCGG sequence methylation pattern of hydroxymethylglutaryl coenzyme A reductase, c-myc, and c-Ha-ras genes, the products of which are related to cell proliferation and carcinogenesis. Therefore, these inhibitory effects of Beta-carotene and vitamin A on progression of hepatocarcinogenesis do not seem to be related to DNA methylation.


Subject(s)
Antioxidants/pharmacology , Liver Neoplasms, Experimental/prevention & control , Vitamin A/pharmacology , beta Carotene/pharmacology , Animals , Cell Division/drug effects , DNA Methylation , Liver/cytology , Liver/pathology , Liver Neoplasms, Experimental/pathology , Male , Random Allocation , Rats , Rats, Wistar , Vitamin A/administration & dosage , beta Carotene/administration & dosage
8.
J Nutr Biochem ; 12(12): 685-692, 2001 Dec.
Article in English | MEDLINE | ID: mdl-12031251

ABSTRACT

The effects of beta-carotene and vitamin A administrations were evaluated in an in vivo model of hepatic cell differentiation. For this purpose, male Wistar rats received beta-carotene (70 mg/kg of body weight), vitamin A (10 mg/kg of body weight) or corn oil (control group), by gavage and at every other day during the entire experimental period. After 4 consecutive weeks of treatment, the animals were submitted to the AAF/PH model of hepatic cell differentiation (6 x 20 mg of AAF [2-acetylaminofluorene]/kg of body weight and partial hepatectomy) and killed on different days following the surgery (until day 16 after hepatectomy). Liver samples were collected for determination of beta-carotene, retinol and retinyl palmitate concentrations, for histopathological (hematoxilin-eosin) examination, for immunohistochemical detection of glutathione S-transferase, as well as for the evaluation of connexin 43 (a structural protein of gap junctions of oval cells) expression by northern blot analysis. Compared to controls, the oval cell proliferation peaks (observed by histopathological examination and immunohistochemistry) and connexin 43 expression peaks, were postponed to later days after hepatectomy, in a similar way in beta-carotene and vitamin A treated animals. Compared to the other experimental groups, the vitamin A treated group showed an increase in connexin 43 expression. It was concluded that beta-carotene and vitamin A modulated oval cell proliferation and connexin 43 expression, delaying both events. These findings suggest that beta-carotene and vitamin A can modulate the hepatic differentiation process in vivo.

9.
Folha méd ; 91(3): 211-7, set. 1985. tab
Article in Portuguese | LILACS | ID: lil-30883

ABSTRACT

O fígado exerce papel fundamental na metabolizaçäo de vários nutrientes. Discute-se, inicialmente, aspectos do metabolismo de: hidratos de carbono, lípides, proteínas, vitaminas e minerais. O efeito das enfermidades hepáticas no estado nutricional e seus respectivos mecanismos säo apresentados. Dentro da terapêutica das hepatopatias o item "dieta" assume papel preponderante. Esta tem por finalidade a prevençäo e o restabelecimento de alteraçöes nutricionais do organismo como um todo e a recuperaçäo da funçäo normal das células hepáticas alteradas. Säo revisados aspectos dietoterápicos do tratamento de formas agudas e crônicas. Comenta-se em detalhe o mecanismo e as propostas terapêuticas em situaçöes de encefalopatia hepática. Desta forma, apresentam-se as modificaçöes da dieta normal como tratamento dirigido às alteraçöes específicas da funçäo metabólica do órgäo


Subject(s)
Humans , Hepatic Encephalopathy/diet therapy , Hepatitis/diet therapy , Liver/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...